EXCLUSIVE: Billionaire Eric Lefkofsky’s Tempus Raises $200 Million To Bring Personalized Medicine To New Diseases The Groupon cofounder’s precision medicine company, which uses AI-based diagnostics, has broadened its focus to infectious disease and cardiology in addition to cancer.